Importance Multiple continuous intravenous anesthetic drugs (CIVADs) are available for the treatment of refractory status epilepticus (RSE). There is a paucity of data comparing the different types of CIVADs used for RSE. Objective To systematically review and compare outcome measures associated with…
Importance Attention-deficit/hyperactivity disorder (ADHD) is associated with increased risks of adverse health outcomes including premature death, but it is unclear whether ADHD pharmacotherapy influences the mortality risk. Objective To investigate whether initiation of ADHD pharmacotherapy was associated with reduced mortality risk in…
Importance Allergic rhinitis affects an estimated 15% of the US population (approximately 50 million individuals) and is associated with the presence of asthma, eczema, chronic or recurrent sinusitis, cough, and both tension and migraine headaches. Observations Allergic rhinitis occurs when disruption of…
Importance More than 40% of US adults have obesity, which increases the risks for multiple chronic diseases and premature mortality. Historically, nonsurgical interventions often have not led to sufficient weight loss and maintenance to improve health, but highly effective antiobesity medications…
Importance Emtricitabine and tenofovir disoproxil fumarate (F/TDF) for HIV preexposure prophylaxis (PrEP) is highly effective in cisgender men who have sex with men (MSM) when adherence is high (>4 doses/week). Real-world effectiveness and adherence with F/TDF for PrEP in cisgender women…
Importance Assessment of type, severity, and impact of dermatologic adverse events (DAEs) necessitates well-developed and validated clinician-reported outcome measures (ClinROMs) and patient-reported outcome measures (PROMs) that evaluate concepts specific to mucocutaneous toxic effects and that allow appropriate interpretation and comparison of…
Addressing the physical, psychological, social, and spiritual needs of dying patients includes pain management. But how have increasing concerns and policies that target opioid misuse impacted pain management options? In this episode, we’ll discuss how balanced opioid policies and maintaining…
Illicit or nonprescribed opioid use in pregnancy has escalated dramatically in recent years, paralleling increases observed in the general population amid the opioid epidemic. As a result, maternal mortality studies in several states have identified substance use as a major…
Advances in genetics research and its application in medical practice have given medical professionals the resources they need to target specific treatments, tailored to patients’ individual needs, environment, and genetic profile. With all the advances in patient care, however, research…
Traditionally, medical treatments have adopted a “one-size-fits-all” approach with what’s been perceived as the “average person” in mind, using characteristics such as genetic makeup or the genetic profile of a disease. Today, we can consider individual differences in people’s genes,…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
